HIMACS (4299) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
20 Jul, 2026Executive summary
Net sales for the nine months ended December 31, 2025, increased 1.1% year-over-year to ¥13,471 million, but operating profit declined 14.0% to ¥1,127 million and profit attributable to owners of parent fell 14.0% to ¥778 million.
Comprehensive income decreased 16.0% year-over-year to ¥748 million for the nine-month period.
Financial highlights
Gross profit for the nine months was ¥2,596 million, down from ¥2,720 million year-over-year.
Basic earnings per share decreased to ¥67.65 from ¥78.08 year-over-year.
Net assets as of December 31, 2025, were ¥10,587 million, with an equity-to-asset ratio of 81.7%.
Cash and cash equivalents at period end were ¥7,113 million, down from ¥8,319 million at the start of the period.
Outlook and guidance
Full-year forecast for fiscal year ending March 31, 2026: net sales of ¥20,000 million (up 10.7% year-over-year), operating profit of ¥1,820 million (up 0.7%), and profit attributable to owners of parent of ¥1,245 million (down 3.7%).
Annual dividend forecast is ¥46.00 per share.
Latest events from HIMACS
- Stable sales and profit growth with positive full-year outlook and robust equity position.4299
Q1 202520 Jul 2026 - Profits and sales rose year-over-year, with strong outlook and higher dividend forecast.4299
Q2 202520 Jul 2026 - Sales and profits rose, with FY2026 sales growth forecast but lower net profit expected.4299
Q4 202520 Jul 2026 - Profits and sales rose year-over-year, with a higher full-year outlook and dividend forecast.4299
Q3 202520 Jul 2026 - Sales rose, but profits fell sharply; full-year outlook sees higher revenue but lower net income.4299
Q1 202620 Jul 2026 - Sales rose modestly, but profits declined; full-year outlook expects higher sales and stable margins.4299
Q2 202620 Jul 2026 - Sales rose modestly, but profits fell and next year's earnings are forecast to decline further.4299
Q4 202620 Jul 2026